La cadena de opciones muestra datos clave de las opciones de acciones de Aprea Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Aprea Therapeutics..

Aprea Therapeutics (NASDAQ:APRE) Bolsa, Cadena de Opciones

APREA THERAPEUTICS INC

Aprea Therapeutics

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Aprea Therapeutics Inc

Health Care

Press Releases

Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial

Adicet Bio Appoints Michael Grissinger to the Board of Directors

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Earnings

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update

General

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update

News

Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

ACET

APRE

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Entero Therapeutics

Ernexa Therapeutics

Evogene

Galmed Pharmaceuticals Ltd. - Ordinary Shares

Galmed Pharmaceuticals

Galecto

Genprex

HCW Biologics

IN8bio

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Mainz Biomed

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Sunshine Biopharma

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Xenetic Biosciences

XTL Biopharmaceuticals Ltd. - American Depositary Shares

Comments

Aprea Therapeutics

Aprea Therapeutics (APRE) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL